Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus

    Osamu Imataki, Haruyuki Fujita, Makiko Uemura in International Journal of Hematology (2024)

  2. No Access

    Article

    Comprehensive procedure for injecting Evusheld® for hematological diseases in a single institute

    Tixagevimab and cilgavimab (EVA, Evusheld®), monoclonal antibody combination treatments, consisted of two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). EVA showe...

    Osamu Imataki, Shunsuke Yoshida, Tomoya Ishida, Makiko Uemura in Annals of Hematology (2024)

  3. Article

    Open Access

    Potential factors for and the prognostic impact of ascites after allogeneic hematopoietic stem cell transplantation

    Ascites is sometimes detected after allogeneic hematopoietic stem cell transplantation (allo-HSCT); however, since limited information is currently available, its clinical meaning remains unclear. Therefore, w...

    Hiroyuki Kubo, Osamu Imataki, Tetsuya Fukumoto, Yui Kawanaka in Scientific Reports (2023)

  4. Article

    Open Access

    Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report

    Acute myeloid leukemia (AML) is a progressive hematological malignancy that can be fatal when left untreated. However, spontaneous remission is rarely observed in the presence of infectious diseases.

    Osamu Imataki, Tomoya Ishida, Jun-ichiro Kida, Makiko Uemura in BMC Infectious Diseases (2023)

  5. No Access

    Article

    Multifocal osteonecrosis after stem cell transplantation

    Osamu Imataki, Makiko Uemura in International Journal of Hematology (2022)

  6. No Access

    Article

    Oral microorganisms and bloodstream infection in allogeneic hematopoietic stem cell transplantation

    We aimed to compare oral and pathogenic microorganisms in bloodstream infections (BSIs) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). We also investigated the relationship between BSIs and...

    Yumiko Ohbayashi, Osamu Imataki, Makiko Uemura in Clinical Oral Investigations (2021)

  7. Article

    Open Access

    Nonclonal chromosomal alterations and poor survival in cytopenic patients without hematological malignancies

    Clonal chromosomal alterations (CCAs) reflect recurrent genetic changes derived from a single evolving clone, whereas nonclonal chromosomal alterations (NCCAs) comprise a single or nonrecurrent chromosomal abn...

    Osamu Imataki, Hiroyuki Kubo, Akihiro Takeuchi, Makiko Uemura in Molecular Cytogenetics (2019)

  8. Article

    Open Access

    Severe rhabdomyolysis associated with severe fever with thrombocytopenia syndrome in a married couple: a case report

    Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infection that has recently emerged. This infectious disease is due to the transfer of SFTS virus (SFTSV) from the infected blood of animals t...

    Osamu Imataki, Makiko Uemura, Hisashi Masugata in BMC Infectious Diseases (2019)

  9. Article

    Open Access

    Effect of ultrasound-guided central venous catheter insertion on the incidence of catheter-related bloodstream infections and mechanical complications

    Central venous catheters (CVCs) are necessary for critically ill patients, including those with hematological malignancies. However, CVC insertion is associated with inevitable risks for various adverse events...

    Osamu Imataki, Mami Shimatani, Yukiko Ohue, Makiko Uemura in BMC Infectious Diseases (2019)

  10. No Access

    Article

    c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia

    D-index is a recently established clinical tool for assessing neutropenia severity. This study examined whether the D-index can predict the onset of various infections in patients with febrile neutropenia (FN).

    Hiroyuki Kubo, Osamu Imataki in International Journal of Clinical Oncology (2019)

  11. No Access

    Article

    Bendamustine and G-CSF support

    Osamu Imataki, Shumpei Uchida, Shigeyuki Yokokura in Supportive Care in Cancer (2019)

  12. Article

    Open Access

    B-chronic lymphocytic leukemia showed triple transformation, to diffuse large B cell, CD20-negative, and T-cell neoplasm during ofatumumab treatment: a case report

    Chronic lymphocytic leukemia (CLL) is a mature lymphoid neoplasm currently categorized as an indolent type of malignant lymphoma. CLL progresses slowly over years, but it eventually transforms to a more aggres...

    Osamu Imataki, Makiko Uemura in BMC Clinical Pathology (2018)

  13. No Access

    Article

    Anemia and hypogammaglobulinemia caused by Ménétrier’s disease

    Osamu Imataki, Shumpei Uchida, Shigeyuki Yokokura in International Journal of Hematology (2018)

  14. Article

    Open Access

    Complete mimicry: a case of alveolar rhabdomyosarcoma masquerading as acute leukemia

    A small number of rhabdomyosarcoma (RMS) cases involve the bone marrow. A leukemic presentation of RMS has been reported in a few case series, although almost all cases of leukemic RMS are not completely mimic...

    Osamu Imataki, Makiko Uemura, Shumpei Uchida, Shigeyuki Yokokura in Diagnostic Pathology (2017)

  15. No Access

    Article

    Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation

    We conducted a retrospective study to evaluate the effect of rehabilitation on minimizing sarcopenia during hematopoietic stem cell transplantation (HSCT) therapy.

    Shouichi Tanaka, Osamu Imataki in Journal of Cancer Research and Clinical On… (2017)

  16. No Access

    Article

    Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation

    Anti-thymocyte globulin (ATG) administered at 5–10 mg/kg can prevent graft-versus-host disease (GVHD). We sought to investigate the potential for lower doses of ATG to decrease non-relapse mortality (NRM).

    Osamu Imataki, Kensuke Matsumoto in Journal of Cancer Research and Clinical On… (2017)

  17. No Access

    Article

    Paradoxical thrombosis in idiopathic thrombocytopenic purpura

    Osamu Imataki, Shumpei Uchida, Shigeyuki Yokokura in International Journal of Hematology (2017)

  18. Article

    Open Access

    Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study

    Extended-spectrum β-lactamase (ESBL)-producing bacteria are resistant to several types of antibiotics excluding carbapenems. A transmissibility of ESBL-producing Enterobacteriaceae would be depending on each b...

    Makiko Uemura, Osamu Imataki, Shumpei Uchida in BMC Infectious Diseases (2017)

  19. No Access

    Article

    Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor

    Although the Sokal and Hasford scoring systems are well-known prognostic models specific to chronic myeloid leukemia (CML), whether they can effectively predict outcomes in elderly CML patients with comorbidit...

    Makiko Uemura, Osamu Imataki, Yasunori Kawachi in International Journal of Hematology (2016)

  20. Article

    Open Access

    Chromosomal abnormality of acute promyelocytic leukemia other than PML-RARA: a case report of acute promyelocytic leukemia with del(5q)

    The recent study described a better outcome in acute promyelocytic leukemia patients treated with all-trans retinoic acid and arsenic oxide compared to those treated with all-trans retinoic acid combined with ...

    Osamu Imataki, Makiko Uemura in BMC Clinical Pathology (2016)

previous disabled Page of 2